A Phase 1 Food-Effect Study of 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects
Latest Information Update: 30 May 2025
At a glance
- Drugs Sildenafil (Primary)
- Indications Erectile dysfunction
- Focus Pharmacokinetics
- Sponsors Aspargo Laboratories
Most Recent Events
- 22 May 2025 Planned End Date changed from 31 May 2025 to 31 Dec 2025.
- 22 May 2025 Planned primary completion date changed from 30 Apr 2025 to 30 Oct 2025.
- 22 May 2025 Status changed from not yet recruiting to recruiting.